Jeff Davies

Dr Davies has over 35 years of biopharmaceutical industry experience, including senior executive roles at CSL. His positions at CSL included Executive Vice President & General Manager, Asia Pacific, where he had full P&L responsibility across pharmaceuticals, plasma, vaccines, and diagnostics in Australia, New Zealand, China, and the broader Asia Pacific. As Global Head of Plasma Product R&D at CSL Behring, he led development of key products, notably the multi-billion-dollar immunoglobulin therapy, Privigen. He is a founding director of the Centre for Biopharmaceutical Excellence, a pharmaceutical consulting firm, and CBE Pure Solutions, a specialist provider of sterile fill finish and microbiological testing services. He has held numerous advisory and board roles, including with the Pharmaceutical Industry Council, Australian Red Cross, and Medicines Australia.